TrialBMC cancer2022

Chemoradiotherapy with concurrent durvalumab for the palliative treatment of oligometastatic oesophageal and gastrooesophageal carcinoma with dysphagia: a single arm phase II clinical trial (PALEO, sponsored by the Australasian Gastro-Intestinal Trials Group).

Fiona Day et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.